Research in IBD at University of Colorado Denver
|
|
- Shon Burke
- 8 years ago
- Views:
Transcription
1 Research in IBD at University of Colorado Denver Blair Fennimore, MD Assistant Professor of Medicine Division of Gastroenterology and Hepatology UCH Crohn s and Colitis Center Mucosal Inflammation Program
2 Epidemiology of PSC-IBD ~1.4 million with IBD in the US ~5% of UC with PSC Up to 90% of PSC with UC >50,000 with IBD in the Mountain West >12,000 along the front range Gastro 2004:126; NEJM 1995:332;
3 Major Regional IBD Centers Rochester, MN Chicago Denver Los Angeles
4 IBD Research Model at UCH Three highly collaborative clinical and basic science research arms Crohn s and Colitis Center Children s Hospital Colorado Pediatric Inflammatory Bowel Disease Center
5 4 P s Physical Proximity Promotes Partnership Mucosal Inflammation Program University of Colorado Hospital Crohn s & Colitis Center Children s Hospital Colorado Pediatric Inflammatory Bowel Disease Center Anschutz Medical Campus Aurora, Colorado
6 A multi-disciplinary center of excellence committed to the identification of novel targets for diagnosis and directed therapy of mucosal disease.
7
8 Cumulative Funding, million Cumulative Funding ($Direct + F&A), million Mucosal Inflammation Program 2007 n= n=49 5 labs 7 specialties Private Donations Foundations 10% 7% 10% Other 7% Fiscal Year NIH 80% 80%
9 Inflammatory Bowel Disease Pathogenesis ~150 genes Complex heredity Genetics Immune System Cytokine Imbalance Immune Medications IBD Environment Gut Bacteria
10 Immunity of IBD Meta-analysis of GWAS (CD 2010, UC 2011) ~150 SNP s 99 total disease loci 28 shared loci >85% of IBD genes relate to Innate Immunity Nature 2011:474;307
11 Ongoing Work in Innate Immunity Autophagy Neutrophil Trafficking Angiogenesis Shifts in the Microbiome Nucleotide Metabolism Oxygen Metabolism
12 Hypoxia in IBD Hypoxia = Low Oxygen Normal Colitis
13 Hypoxia Inducible Factor - HIF α β + = α β HIF Normoxia Hypoxia O 2 O 2 α O 2 α HO α α Hypoxia α HO α α + β α β Gene Transcription DNA
14 HIF in Mouse Models of Colitis HIF Knockout Mice DSS Colitis Body weight Barrier Healthy Mice Control Colitis Mutant Colitis + - Colitis
15 HIF in Mouse Models of Colitis AKB-4924 Treatment HIF Stabilizer ( HIF levels) O 2 O 2 O 2 α α β α Body weight Healthy Mice Disease Activity Colitis Colitis + AKB-4294 Colitis + Steroids Colitis Colitis + Steroids Colitis + AKB-4294 Healthy Mice
16 HIF in Mouse Models of Colitis Colitis Healthy Colitis + AKB-4294 HIF is protective in colitis AKB-4924 (HIF mimetic) is a potential therapeutic option Phase I Clinical Trials
17 Creatine Metabolism P ATP ADP Creatine Creatine Kinase P Phospho Creatine P ATP
18 Creatine as a Biomarker in Colitis Creatine Concentration TNBS Colitis Healthy Colitis Creatine Phospho Creatine PCr/Cr Ratio
19 Decreased Levels of CK in Human IBD Creatine Kinase Levels in IBD CK Staining in IBD Normal Normal Crohn s UC Abnormal Creatine/Phospho- Creatine Pathway in IBD Ulcerative Colitis PNAS 2013:110;
20 Creatine Supplements in Colitis Healthy Colitis Colitis + 2% Cr Creatine supplementation improved colitis severity in a mouse model
21 UCH Crohn s and Colitis Center Crohn s and Colitis Center
22 UCH Crohn s and Colitis Center
23 Clinical Research in IBD at UCH RESEARCH IBD Database Umbrella protocol Disease Phenotype Disease Activity Measures Biorepository: > 500 patients Serum Tissue Clinical Trials: CCFA Clinical Research Alliance - MERIT-UC - PUCCINI Industry-Sponsored studies - Placental Stem Cell infusions Investigator-Initiated studies - Creatine supplementation IBD Clinic POPULATION MGMT Evidence-Based Care QI Initiatives Performance Measurement - PQRS: AGA BTE Program
24 Clinical Research Trials MERIT-UC NIH funded study using Methotrexate in UC PUCCINI Study to clarify the risks associated with the use of IBD medications at the time of surgery Placental Stem Cell Infusion Study of placental stem cell infusions as adjunct therapy in severe/refractory Crohn s disease Creatine Supplementation in UC Study of Creatine supplementation in treatment of mild-moderate UC
25 IBD Research at UCH Exciting ongoing research through the MIP and UCH Crohn s and Colitis Center Basic science Translational research Clinical trials in new IBD therapies Quality improvement initiatives in patient care Multidisciplinary approach to clinical IBD care
26 Thank You
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...
More informationFocus Biobank Inflammatory Bowel Disease
Focus Biobank Inflammatory Bowel Disease University Hospitals Leuven KU Leuven Isabelle Cleynen, PhD Inflammatory Bowel Disease Crohn s disease (CD) Entire GI tract Transmural Fistulas and/or strictures
More informationCrohn s and Colitis Center
Crohn s and Colitis Center Dedicated to caring for patients with inflammatory bowel disease Crohn s disease and ulcerative colitis. The Crohn s and Colitis Center is the only center in New England exclusively
More informationAutoimmunity and immunemediated. FOCiS. Lecture outline
1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic
More informationCrohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals. Sponsored Research Program in Inflammatory Bowel Disease
Crohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals Sponsored Research Program in Inflammatory Bowel Disease Presentation Overview Background on inflammatory bowel disease Partner Overview
More informationIn vitro co-culture model of the inflamed intestinal mucosa
In vitro co-culture model of the inflamed intestinal mucosa Berlin, December 13, 2011 Eva-Maria Collnot, e.collnot@mx.uni-saarland.de Helmholtz Institute for Pharmaceutical Research Saarland Departement
More informationDietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Andrew T. Gewirtz et al N A T U R E VOL 519 5 M A R C H 2 0 1 5 Background Incidence of IBD Fact 1: increasing
More informationProbiotics for the Treatment of Adult Gastrointestinal Disorders
Probiotics for the Treatment of Adult Gastrointestinal Disorders Darren M. Brenner, M.D. Division of Gastroenterology Northwestern University, Feinberg School of Medicine Chicago, Illinois What are Probiotics?
More information5 Frequently Asked Questions About Adult Stem Cell Research
5 Frequently Asked Questions About Adult Stem Cell Research Stem cells are often referred to in the sociopolitical realm with some level of controversy and beyond that, some level of confusion. Many researchers
More informationThis year, I began my term of office as the new
A MESSAGE FROM RICHARD S. BLUMBERG, M.D. Chairperson, National Scientific Advisory Committee This year, I began my term of office as the new Chairperson of the National Scientific Advisory Committee (NSAC).
More informationGive a NOD to diabetes:
Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical
More informationUnderstanding Colitis and Crohn s Disease
Improving life for people affected by Colitis and Crohn s Disease Understanding Colitis and Crohn s Disease 1 Understanding Colitis and Crohn s Disease Understanding Ulcerative Colitis and Crohn s Disease...
More informationimproving lives through collaborative medicine
improving lives through collaborative medicine ImproveCareNow is a collaborative chronic care network of 77 care centers in 35 states and the District of Columbia and England, where clinicians, researchers,
More informationHUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE
HUNTINGTON S DISEASE MULTIDISCIPLINARY CLINIC HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE From gene to treatments The gene that causes Huntington s disease (HD) was discovered in 1993. Since then, enormous
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationChallenges in IBD Research: Updating the Scientific Agendas
Inflammatory Bowel Diseases 9(3):137 153 2003 Crohn s & Colitis Foundation of America, Inc. Challenges in IBD Research: Updating the Scientific Agendas *Charles O. Elson, R. Balfour Sartor, Stephan R.
More information11/10/2014. New Treatments in IBD: When, Whom and How. Background. Background. Options. Disease Assessment. What is the evidence?
New Treatments in IBD: When, Whom and How. Background Options Disease Assessment What is the evidence? Kofi Clarke MD, FACP,FRCP (Lond) Clinical Associate Professor, Chief, Gastroenterology, Hepatology
More informationSubproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases
Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg,
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationSupport Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
More informationTHIRD ANNUAL PEDIATRIC INFLAMMATORY BOWEL DISEASE RESEARCH DAY SEPTEMBER 18, 2015. Weill Cornell Medical College
THIRD ANNUAL PEDIATRIC INFLAMMATORY BOWEL DISEASE RESEARCH DAY SEPTEMBER 18, 2015 Gerald M. Loughlin, MD, MS & Robbyn E. Sockolow, MD, AGAF REGISTRATION & BREAKFAST 7:00 AM-8:00 AM Welcome & Introduction
More informationCytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
More informationEvidence of Crohn s Disease. Case Presentation
Witt Wait to Treat tutiled Until Endoscopic Evidence of Crohn s Disease Raymond Cross, MD, MS, AGAF Associate Professor of Medicine Director, IBD Program University of Maryland School of Medicine Co-Director,
More informationBSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY
BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationCurrent and Future Applications of Probiotic Science
Current and Future Applications of Probiotic Science Patricia L Hibberd, MD, PhD Chief, Division of Global Health Department of Pediatrics Massachusetts General Hospital, Boston Disclosures Probiotics
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationTHE EFFECTS OF TREADMILL AND VOLUNTARY WHEEL TRAINING ON MORBIDITY AND INFLAMMATION DURING ULCERATIVE COLITIS IN MICE MARC D.
THE EFFECTS OF TREADMILL AND VOLUNTARY WHEEL TRAINING ON MORBIDITY AND INFLAMMATION DURING ULCERATIVE COLITIS IN MICE BY MARC D. COOK DISSERTATION Submitted in partial fulfillment of the requirements for
More informationALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES
ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES DESCRIPTION OF GRANT MECHANISM The Alliance for Lupus Research (ALR) is an independent,
More informationGraduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose
More informationJohn I Allen, MD, MBA
Specialty Clinical Service Lines John I Allen, MD, MBA Minnesota Gastroenterology American Gastroenterological Association ICSI Accountable Care Organization Primary Care Specialty Care Outpatient Care
More information2nd MuscleTech Network Workshop. From translational Research to translational Medicine. CONCLUSIONS AND CLOSING REMARKS Dr.
2nd MuscleTech Network Workshop. From translational Research to translational Medicine. CONCLUSIONS AND CLOSING REMARKS Dr. Carles Pedret MUSCLE AND TENDON WORKSHOP HEALTH AND GENERAL POPULATION SPORTS
More informationMicroscopic Colitis: Collagenous Colitis and Lymphocytic Colitis
Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is
More information03/20/12. Recognize the right of patients to appropriate assessment and management of pain
Narcotic Bowel Syndrome Alvin Zfass M.D. M.D. Professor of Medicine Toufic Kachaamy M.D. GI Fellow Chronic Pain 110 million Americans suffer from chronic pain according to the NIH Cost of untreated t or
More informationProspects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS
Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates
More informationTHE UNIVERSITY OF OXFORD MEDICAL SCIENCES DIVISION. Final Report to Cure Crohn s Colitis
THE UNIVERSITY OF OXFORD MEDICAL SCIENCES DIVISION Final Report to Cure Crohn s Colitis MARCH 2008 CONTENTS Introduction 2 Project background 3 Crohn s and Colitis research at Oxford 4 Project progress
More informationPediatric Gastroenterology Fellowship Pediatric Nutrition Rotation Goals and Objectives - 1 st Year
Pediatric Nutrition Rotation Goals and Objectives - 1 st Year Goal 1: Gain experience and competency in managing common and rare gastrointestinal, liver and nutritional problems. (Competencies: patient
More informationAdult Inflammatory Bowel Disease Physician Performance Measures Set. August 2011*
Adult Inflammatory Bowel Disease Physician Performance Measures Set August 2011* *Last revised on October 26, 2011 American Gastroenterological Association Adult Inflammatory Bowel Disease Physician Performance
More informationUlcerative colitis patients with low grade dysplasia should undergo frequent surveillance colonoscopies
Ulcerative colitis patients with low grade dysplasia should undergo frequent surveillance colonoscopies David T. Rubin, MD, FACG, AGAF Associate Professor of Medicine Co-Director, Inflammatory Bowel Disease
More informationPharmacology of the Respiratory Tract: COPD and Steroids
Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationFuture Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
More informationChild and Maternal Health Research Program
Child and Maternal Health Research Program William W. Hay, Jr.. MD (Pediatrics/Neonatology) Objectives of CMH Program The CMH program raises awareness of: CMH investigators within the CCTSI of ongoing
More informationINFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASE Update for Advanced Practice Clinicians and Allied Health Professionals Join Us... Friday, April 24, 2015 University Conference Center Penn State Milton S. Hershey Medical Center
More informationLEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
More informationLeukapheresis for inflammatory bowel disease
Issue date: June 2005 Leukapheresis for inflammatory bowel disease Understanding NICE guidance information for people considering the procedure, and for the public Information about NICE Interventional
More informationTop Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms. Stephen B. Hanauer, M.D. University of Chicago
Top Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms Stephen B. Hanauer, M.D. University of Chicago Treatment Goals c.2008 Induce and maintain response/remission Prevent complications Disease
More informationGene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
More informationGriffith University - Case for Support. Mesothelioma Research Program
Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health
More informationPersonalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
More informationThe ethics of stem cell research and treatment
The ethics of stem cell research and treatment Bernard Lo, M.D. March 12, 2009 1 hesc: ethical controversies Moral status of embryo? Clearly a potential person Some believe a person with rights Is hesc
More informationArthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
More informationUlcerative colitis (UC) is an idiopathic inflammatory
ORIGINAL ARTICLE Fecal Bacteriotherapy for Ulcerative Colitis: Patients Are Ready, Are We? Stacy A. Kahn, MD,* Rita Gorawara-Bhat, PhD, and David T. Rubin, MD Background: Fecal bacteriotherapy (FB) has
More informationA link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us
A link between gut microbiota, mucosal immunity and autoimmune arthritis Microbes and Man The majority of microbes we encounter are gut microbiota that live mostly in harmony with their host Duodenum 10
More informationCanadian Microbiome Initiative
Canadian Microbiome Initiative Background The human body plays host to trillions of microbes, including bacteria, viruses and protists. These microbes constitute the Human Microbiome that resides both
More informationWhat to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic
What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning
More informationCrohn s Disease. What I need to know about. U.S. Department of Health and Human Services
What I need to know about Crohn s Disease NATIONAL INSTITUTES OF HEALTH National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services What I need to know about Crohn
More informationDrug Development Services
Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through
More informationUnderstanding West Nile Virus Infection
Understanding West Nile Virus Infection The QIAGEN Bioinformatics Solution: Biomedical Genomics Workbench (BXWB) + Ingenuity Pathway Analysis (IPA) Functional Genomics & Predictive Medicine, May 21-22,
More informationAsthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System
1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID
More informationPrinciples of Gastroenterology. Nurse Practitioner and Physician Assistant. for the. Aug. 10 12, 2012 InterContinental Chicago
Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant Aug. 10 12, 2012 InterContinental Chicago Course Directors Lawrence R. Kosinski, MD, MBA, AGAF, FAGC Sandra Bernklau, MSN,
More informationJUMISC JUMISC. For further information visit our website:
STEM CELL THERAPY COMPANY PROFILE & SCIENTIFIC ACTIVITIES For further information visit our website: WWW.CCMIJESUSUSON.COM 20 14 JUMISC JUMISC Carretera N-521, km. 41,8 10071 CÁCERES (SPAIN) Tel. (+34)
More informationIndividualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More informationNutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment
Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment Collaborative on Health and the Environment June 17, 2014 Ted Schettler MD, MPH 1 Autoimmune diseases Autoimmunity
More informationHUMAN STEM CELLS DERIVED FROM CORD BLOOD REDUCES THE SIZE OF PANCREATIC TUMOR IN SCID MICE.
HUMAN STEM CELLS DERIVED FROM CORD BLOOD REDUCES THE SIZE OF PANCREATIC TUMOR IN SCID MICE. Jay P Sharma***, Saroj K. Basak ++ ***CELPROGEN INC., SAN PEDRO, CA 90731; ++ University of California (UCLA),
More informationEVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze
EVIDENCE BASED TREATMENT OF CROHN S DISEASE Dr E Ndabaneze PLAN 1. Case presentation 2. Topic on Evidence based Treatment of Crohn s disease - Introduction pathology aetiology - Treatment - concept of
More informationCROHN S & COLITIS FOUNDATION OF AMERICA. Senior Research Award INSTRUCTIONS. Effective September 2013
CROHN S & COLITIS FOUNDATION OF AMERICA Senior Research Award INSTRUCTIONS Effective September 2013 Crohn s & Colitis Foundation of America National Office Research & Scientific Programs Department 733
More informationCrohn s Disease. What is Crohn s Disease? ho gets Crohn s Disease? hat are the symptoms? What causes Crohn s Disease?
In association with: Primary Care Society for Gastroenterology INFORMATION ABOUT Crohn s Disease What is Crohn s Disease? ho gets Crohn s Disease? What causes Crohn s Disease? hat does it do to the intestine?
More informationOSCCAR: Ocean State Crohn s and Colitis Area Registry
82 OSCCAR: Ocean State Crohn s and Colitis Area Registry Bruce E. Sands, MD, MS, Neal LeLeiko, MD, PD, Samir A. Shah, MD, FACG, Renee Bright, MS, Stacey Grabert, PharmD, MS Epidemiology studies describe
More informationCrohn's and Colitis UK Information Sheet. Students with IBD: a guide for universities and colleges
Crohn's and Colitis UK Information Sheet Improving life for people affected by inflammatory bowel diseases Students with IBD: a guide for universities and colleges Introduction It is very likely that several
More informationSuccesses and Limitations of Targeted Therapies in Renal Cell Carcinoma
g Tumor Res. Basel, Karger, 2014, vol 41, pp 98 112 (DOI: 10.1159/000355906) Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma Marc Pracht Dominik Berthold Medical Oncology Unit,
More information2012 International Conference
2012 International Conference The 15th International Congress on Behçet s Disease was held at the Conference Centre in Yokohama, Japan, on 13 15 July 2012. It proved to be an excellent meeting, with many
More informationCOPD, INFLAMMATION, AND LUNG CANCER. Jerome S Brody, M.D., Professor of Medicine and. Avrum Spira, M.D., Assistant Professor of Medicine
COPD, INFLAMMATION, AND LUNG CANCER Jerome S Brody, M.D., Professor of Medicine and Avrum Spira, M.D., Assistant Professor of Medicine Pulmonary Center and Department of Medicine Boston University School
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationReview of CBER's Current and Planned Post-marketing Safety Practices
Review of CBER's Current and Planned Post-marketing Safety Practices Robert Ball MD, MPH, ScM Director, Office of Biostatistics and Epidemiology (OBE), Center for Biologics Evaluation and Research (CBER),
More informationSeminar/Talk Calendar
Seminar/Talk Calendar Tuesday, February 3rd Dr. John Neumaier, Professor of Psychiatry and Pharmacology, University of Washington DREADDing Addiction Dr. Neumaier s laboratory is studying stress and addiction
More informationStem Cell Quick Guide: Stem Cell Basics
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
More informationLA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti. Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova
LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova HBV ed HCV Due virus Diversi ma con molte Cose in Comune
More informationRole Of Mitochondria In Mesenchymal Stem Cells
Role Of Mitochondria In Mesenchymal Stem Cells Roman Eliseev, MD, PhD, Tamara Raymond, Regis O'Keefe, MD, PhD. University of Rochester, Rochester, NY, USA. Disclosures: R. Eliseev: None. T. Raymond: None.
More informationDisclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
More informationUniversity of Colorado Denver Anschutz Medical Campus. Department of Bioengineering. Engineering the Future of Medicine
University of Colorado Denver Anschutz Medical Campus Department of Bioengineering Engineering the Future of Medicine Thanks to bioengineering, medical advances once only imagined are becoming reality.
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Tysabri
MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF I. Requirements for Prior Authorization of Tysabri A. Prescriptions That Require Prior Authorization All prescriptions for Tysabri must be prior authorized.
More informationCenter for Endoscopic Research & Therapeutics
Center for Endoscopic Research & Therapeutics 5758 South Maryland Avenue (MC9028) Chicago, Illinois 60637 (773) 702-1459 www.uchospitals.edu Center for Endoscopic Research & Therapeutics To refer a patient
More informationA Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm
A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm Zi Ye, 1 MD, Erin Austin, 1,2 PhD, Daniel J Schaid, 2 PhD, Iftikhar J. Kullo, 1 MD Affiliations: 1 Division of Cardiovascular Diseases and
More informationRheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine
Rheumatology Labs for Primary Care Providers Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine Objectives Review the Indications for and Interpretation of lab testing for the following diseases:
More informationDavid M. Underhill, Ph.D.
David M. Underhill, Ph.D. Inflammatory Bowel & Immunobiology Research Institute Cedars-Sinai Medical Center, Los Angeles & UCLA Dept. of Pathology and Laboratory Medicine http://www.customprobiotics.com/about_probiotics.htm
More information1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.
Endotoxicity and Cytotoxicity Studies 1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Chinese Hamster Ovary (CHO) cells were grown in monolayer with and without metabolic activation.
More informationInflammatory. Bowel Disease. New Advances in. September 19-20, 2015 Hilton San Diego/Del Mar San Diego, California
Inflammatory New Advances in September 19-20, 2015 Hilton San Diego/Del Mar San Diego, California c o n f e r e n c e h i g h l i g h t s Plenary talks from industry leading experts Interactive case presentations
More informationVitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
More informationKentucky Lung Cancer Research Program. 2010 Strategic Plan Update
Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated
More informationCord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us
More informationIKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics
Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex
More informationis working on is about nutrition, specifically as it pertains to Alpha- continued on page 2
Alpha-1 Canada Update May 2010 It has been very busy here over the last few months. Well it always seems to be busy, but lately exceptionally so. As this newsletter goes to press we are only days away
More informationSUNY UPSTATE MEDICAL UNIVERSITY
Clinical Update May 2007 Major Players: Nurse Practitioners At University Hospital, 120 nurse practitioners make a profound contribution to the quality and scope of services. Page A2 Paving the Way to
More informationChoosing Outcome Measures in Pediatric IBD. Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada
Choosing Outcome Measures in Pediatric IBD Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada Disclosures The content of this presentation reflect my personal opinions
More informationThe Oxford IBD Service
Gastroenterology Unit, John Radcliffe Hospital The Oxford IBD Service Information for patients Information for patients 1 The Oxford Inflammatory Bowel Disease (IBD) Service Consultant Gastroenterologists
More informationPPD LABORATORIES CENTRAL LAB: SUPERIOR SERVICE, QUALITY DATA WITHOUT COMPROMISES
PPD LABORATORIES CENTRAL LAB: SUPERIOR SERVICE, QUALITY DATA WITHOUT COMPROMISES PPD Laboratories provides world-class scientific expertise with state-of-the-art technologies supported by a commitment
More informationAdvanced Nursing Research in Critical Care
12 th Congress of the World Federation of Societies of Intensive and Critical Care Medicine Advanced Nursing Research in Critical Care Yeonsoo Jang RN, PhD. Assistant Professor Yonsei University College
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More information